Target intelligence / Profile preview

Gap junction protein beta 5 (GJB5 or Cx31.1)

Target
GJB5 or Cx31.1
Molecular classification
Connexin family protein, Gap junction protein, Ion channel (specifically, channel-forming protein), Membrane protein, Beta-type connexin
01

Overview

Gap junction protein beta 5 is a member of the connexin family, encoded by the GJB5 gene, and also known as connexin-31.1 (Cx31.1)[3][1]. It forms transmembrane channels (gap junctions) which allow direct transfer of small molecules, ions, and signaling mediators between adjacent cells. These gap junctions are crucial for cell-to-cell electrical and metabolic communication, especially in the epidermis and various epithelial tissues[1][3][2][7]. Mutations in GJB5 can result in inherited skin disorders and have been linked to certain cancers, such as non-small cell lung cancer. The channel complexes formed by this protein are essential for tissue homeostasis, developmental processes, and environmental sensing[1][3]. While direct therapeutic targeting has not been established, its central role in disease highlights potential for drug development or biomarker use.

Other names
Connexin-31.1GJB5Cx31.1
02

Mechanism of action

Channel modulation (for hypothetical or future drugs, regulation of gap junction communication or blocking the channel)

03

Biological functions

Intercellular communicationIon and metabolite transferSignal transductionEpidermal differentiationEnvironmental sensing
04

Disease associations

Cancer (notably non-small cell lung cancer)Skin diseases (e.g., palmoplantar keratoderma, Bart-Pumphrey syndrome, congenital alopecia)Neurological disease (implicated by analogy with other connexins)
05

Safety considerations

Abnormal channel function can disrupt cell communication, potentially leading to diseases such as cancer or skin disordersGiven its role in skin and other tissue homeostasis, off-target effects in these systems may be a concern for any future therapeutics
06

Biomarkers

Potential biomarker for non-small cell lung cancerPotential skin disease marker

Beyond the preview

Go deeper on Gap junction protein beta 5 (GJB5 or Cx31.1).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Gap junction protein beta 5 (GJB5 or Cx31.1).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call